Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

Remote neuromodulation may offer safe, effective relief for a range of migraine types, including those with aura and chronic ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

Chronic migraine sufferers who have not been able to find relief with available migraine drugs might now have hope in a new option. A new pilot study from Italian researcher Simone Braca and his ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...